Seamless Therapeutics entered into a strategic global research collaboration and licensing agreement with Eli Lilly and ...

Collaboration will advance a next generation gene editing approach by combining Seamless’ expertise in developing highly precise and efficient ...

Eli Lilly plans to expand its hearing loss therapy pipeline by collaborating with Seamless Therapeutics to apply the company’s next-generation gene-editing approach, based on programmable recombinases ...